| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | filamin binding | 1.86e-05 | 29 | 110 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | chromatin binding | TPR TSHZ3 ZEB1 ERCC6 EP400 SREBF1 SREBF2 PHF8 PHF21A WAC KAT7 KAT2B CABIN1 HCFC1 | 5.49e-05 | 739 | 110 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 5.66e-05 | 14 | 110 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 7.05e-05 | 15 | 110 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 2.66e-04 | 23 | 110 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | NACA MED14 JADE1 PHF8 KAT7 KAT2B BRD8 TAF9B ATF7IP MTDH HCFC1 | 2.74e-04 | 562 | 110 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | protein dimerization activity | TPR NRBP1 ZHX3 LILRA2 SLK FOXP2 PSG2 PSG4 PSG9 SREBF1 SREBF2 ZHX2 GTF2A1 ABCB10 TAF9B TRIM9 MGA | 3.11e-04 | 1205 | 110 | 17 | GO:0046983 |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 5.35e-04 | 29 | 110 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TPR SYNPO2 NACA MED14 JADE1 PHF8 WNK1 KAT7 KAT2B BRD8 SHANK2 TAF9B ATF7IP RBM47 MTDH HCFC1 | 6.08e-04 | 1160 | 110 | 16 | GO:0030674 |
| GeneOntologyMolecularFunction | phosphatase binding | 6.52e-04 | 264 | 110 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 8.60e-04 | 34 | 110 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | transcription factor binding | FOXP2 NACA SREBF1 MED14 GTF2A1 KAT2B BRD8 LATS1 ARID2 MTDH HCFC1 LRIF1 | 9.06e-04 | 753 | 110 | 12 | GO:0008134 |
| GeneOntologyMolecularFunction | histone H4K16 acetyltransferase activity | 1.06e-03 | 9 | 110 | 2 | GO:0046972 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 1.06e-03 | 9 | 110 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.09e-03 | 210 | 110 | 6 | GO:0019903 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.45e-03 | 303 | 110 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase inhibitor activity | 1.49e-03 | 41 | 110 | 3 | GO:0030291 | |
| GeneOntologyMolecularFunction | histone H4K8 acetyltransferase activity | 1.60e-03 | 11 | 110 | 2 | GO:0043996 | |
| GeneOntologyMolecularFunction | histone H4K5 acetyltransferase activity | 1.60e-03 | 11 | 110 | 2 | GO:0043995 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.69e-03 | 229 | 110 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | TPR NRBP1 ZHX3 LILRA2 SLK FOXP2 PSG2 PSG4 PSG9 ZHX2 ABCB10 TRIM9 | 1.77e-03 | 815 | 110 | 12 | GO:0042803 |
| GeneOntologyMolecularFunction | histone H4K12 acetyltransferase activity | 1.91e-03 | 12 | 110 | 2 | GO:0043997 | |
| GeneOntologyMolecularFunction | glycolipid binding | 2.49e-03 | 49 | 110 | 3 | GO:0051861 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | TPR MMS22L ERCC6 EP400 ACTR5 LIN54 MED14 POGZ JADE1 PHF8 PHF21A WAC KAT7 GTF2A1 KAT2B BRD8 ATF7IP ARID2 CABIN1 HCFC1 PRDM6 LRIF1 | 8.60e-09 | 999 | 108 | 22 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | TPR MMS22L ERCC6 EP400 ACTR5 LIN54 JADE1 PHF8 PHF21A WAC KAT7 KAT2B BRD8 ATF7IP ARID2 CABIN1 HCFC1 PRDM6 LRIF1 | 1.86e-07 | 896 | 108 | 19 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | TPR ERCC6 EP400 ACTR5 LIN54 JADE1 PHF8 WAC KAT7 KAT2B ATF7IP ARID2 CABIN1 HCFC1 PRDM6 LRIF1 | 1.53e-06 | 741 | 108 | 16 | GO:0006338 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZEB1 ERCC6 NACA SREBF1 SREBF2 MED14 AKNA POGZ PHF8 KAT7 GTF2A1 KAT2B BRD8 KLF10 ARID2 CAPRIN2 GMEB1 SIX5 MGA HCFC1 ZNF292 | 9.26e-06 | 1390 | 108 | 21 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 1.11e-05 | 266 | 108 | 9 | GO:0033044 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 2.06e-05 | 362 | 108 | 10 | GO:0010948 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | 3.22e-05 | 464 | 108 | 11 | GO:0045786 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TPR ZHX3 ZEB1 FOXP2 SCAF8 NACA SREBF1 SREBF2 ZHX2 PHF21A KAT2B KLF10 TAF9B ATF7IP MTDH HCFC1 PRDM6 | 3.25e-05 | 1053 | 108 | 17 | GO:0000122 |
| GeneOntologyBiologicalProcess | DNA repair | EME1 MMS22L EXOSC10 ERCC6 EP400 ACTR5 POGZ USP44 KAT7 KAT2B BRD8 ARID2 PRPF19 | 3.43e-05 | 648 | 108 | 13 | GO:0006281 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TPR ZHX3 TSHZ3 ZEB1 FOXP2 SCAF8 NACA SREBF1 SREBF2 ZMYM2 ZHX2 PHF21A KAT2B KLF10 TAF9B ATF7IP SIX5 MTDH HCFC1 PRDM6 | 3.46e-05 | 1399 | 108 | 20 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TPR ZHX3 TSHZ3 ZEB1 FOXP2 SCAF8 NACA SREBF1 SREBF2 ZMYM2 ZHX2 PHF21A KAT2B KLF10 TAF9B ATF7IP SIX5 MTDH HCFC1 PRDM6 | 3.99e-05 | 1413 | 108 | 20 | GO:1902679 |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 4.06e-05 | 73 | 108 | 5 | GO:0042304 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 4.87e-05 | 14 | 108 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 5.22e-05 | 324 | 108 | 9 | GO:0006302 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 6.07e-05 | 15 | 108 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 6.07e-05 | 15 | 108 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 6.07e-05 | 15 | 108 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.07e-05 | 15 | 108 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 7.44e-05 | 16 | 108 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | neuroblast division in subventricular zone | 8.12e-05 | 3 | 108 | 2 | GO:0021849 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair via homologous recombination | 8.21e-05 | 44 | 108 | 4 | GO:1905168 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | TPR EME1 WAPL ERCC6 EP400 ACTR5 JADE1 WNK1 TTK WAC USP44 KAT7 KAT2B BRD8 LATS1 ARID2 PRPF19 HCFC1 | 8.75e-05 | 1256 | 108 | 18 | GO:0051726 |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 9.00e-05 | 17 | 108 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 9.00e-05 | 17 | 108 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 9.00e-05 | 17 | 108 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of transferase activity | 9.55e-05 | 273 | 108 | 8 | GO:0051348 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.08e-04 | 18 | 108 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | DNA damage response | EME1 MMS22L EXOSC10 ERCC6 EP400 ACTR5 POGZ WAC USP44 KAT7 KAT2B BRD8 TAF9B ARID2 PRPF19 | 1.41e-04 | 959 | 108 | 15 | GO:0006974 |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 1.47e-04 | 217 | 108 | 7 | GO:0000075 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.49e-04 | 20 | 108 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 1.62e-04 | 4 | 108 | 2 | GO:1904594 | |
| GeneOntologyBiologicalProcess | negative regulation of protein kinase activity | 1.64e-04 | 221 | 108 | 7 | GO:0006469 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.73e-04 | 21 | 108 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.73e-04 | 21 | 108 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.73e-04 | 21 | 108 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | regulation of cell development | LILRA2 ZEB1 PSG2 PSG4 PSG9 NACA MCF2 KAT7 KLF10 ABCB10 SYNJ1 ARID2 CAPRIN2 NUMB PRPF19 MYRF | 1.81e-04 | 1095 | 108 | 16 | GO:0060284 |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 2.00e-04 | 22 | 108 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 2.29e-04 | 23 | 108 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.29e-04 | 23 | 108 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | 2.33e-04 | 311 | 108 | 8 | GO:1901988 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 2.33e-04 | 234 | 108 | 7 | GO:0006282 | |
| GeneOntologyBiologicalProcess | negative regulation of kinase activity | 2.46e-04 | 236 | 108 | 7 | GO:0033673 | |
| GeneOntologyBiologicalProcess | negative regulation of chromosome organization | 2.49e-04 | 107 | 108 | 5 | GO:2001251 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 2.59e-04 | 59 | 108 | 4 | GO:0045671 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 2.61e-04 | 24 | 108 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 2.61e-04 | 24 | 108 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 2.61e-04 | 24 | 108 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | regulation of heterochromatin formation | 2.61e-04 | 24 | 108 | 3 | GO:0031445 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 2.69e-04 | 5 | 108 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid segregation | 2.77e-04 | 60 | 108 | 4 | GO:0033047 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 2.95e-04 | 25 | 108 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 2.95e-04 | 25 | 108 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 2.96e-04 | 111 | 108 | 5 | GO:0033045 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 3.14e-04 | 62 | 108 | 4 | GO:0032786 | |
| GeneOntologyBiologicalProcess | negative regulation of protein modification process | 3.58e-04 | 512 | 108 | 10 | GO:0031400 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 3.63e-04 | 116 | 108 | 5 | GO:0045670 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 3.73e-04 | 27 | 108 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 3.83e-04 | 254 | 108 | 7 | GO:0000819 | |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 4.02e-04 | 6 | 108 | 2 | GO:0031554 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 4.16e-04 | 28 | 108 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 4.23e-04 | 67 | 108 | 4 | GO:0045601 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | 4.49e-04 | 627 | 108 | 11 | GO:0044770 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 4.62e-04 | 29 | 108 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 4.69e-04 | 188 | 108 | 6 | GO:0000724 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | EME1 MMS22L EXOSC10 WAPL ERCC6 EP400 ACTR5 POGZ JADE1 USP44 KAT7 KAT2B BRD8 ARID2 PRPF19 | 5.06e-04 | 1081 | 108 | 15 | GO:0006259 |
| GeneOntologyBiologicalProcess | recombinational repair | 5.54e-04 | 194 | 108 | 6 | GO:0000725 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 5.64e-04 | 31 | 108 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TPR EXOSC10 SYNPO2 WAPL ACTR5 VPS13C SREBF1 SREBF2 TTK USP44 KAT2B LATS1 SYNJ1 TRIM9 ATF7IP ARID2 LIMCH1 | 5.93e-04 | 1342 | 108 | 17 | GO:0033043 |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 6.20e-04 | 32 | 108 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 6.20e-04 | 32 | 108 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 6.20e-04 | 32 | 108 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 6.79e-04 | 33 | 108 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 6.79e-04 | 33 | 108 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | growth | ERCC6 RAPH1 FOXP2 PSG2 PSG4 PSG9 NACA JADE1 COLQ IGSF10 KAT7 LATS1 TAF9B ARID2 CAPRIN2 VPS13A | 6.86e-04 | 1235 | 108 | 16 | GO:0040007 |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 7.01e-04 | 134 | 108 | 5 | GO:0019217 | |
| GeneOntologyBiologicalProcess | DNA recombination | 7.11e-04 | 368 | 108 | 8 | GO:0006310 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 7.42e-04 | 34 | 108 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 7.42e-04 | 34 | 108 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 7.59e-04 | 564 | 108 | 10 | GO:0051052 | |
| GeneOntologyBiologicalProcess | behavior | LILRA2 FOXP2 PSG2 PSG4 PSG9 PHF21A KAT2B SHANK2 P2RX3 SYNJ1 VPS13A OTOG DNAH11 | 7.75e-04 | 891 | 108 | 13 | GO:0007610 |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 8.07e-04 | 288 | 108 | 7 | GO:0045637 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 8.09e-04 | 35 | 108 | 3 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 8.27e-04 | 139 | 108 | 5 | GO:0051983 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA recombination | 8.28e-04 | 80 | 108 | 4 | GO:0045911 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | ZHX3 TSHZ3 ZEB1 PSG2 PSG4 PSG9 KAT7 KLF10 ABCB10 SYNJ1 ARID2 CAPRIN2 NUMB PRPF19 MYRF | 8.81e-04 | 1141 | 108 | 15 | GO:0045597 |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 9.39e-04 | 143 | 108 | 5 | GO:0045739 | |
| GeneOntologyBiologicalProcess | chromosome organization | TPR EXOSC10 WAPL ACTR5 POGZ TTK USP44 KAT2B LATS1 ATF7IP ARID2 | 9.42e-04 | 686 | 108 | 11 | GO:0051276 |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via homologous recombination | 9.51e-04 | 83 | 108 | 4 | GO:0010569 | |
| GeneOntologyBiologicalProcess | regulation of mitophagy | 1.03e-03 | 38 | 108 | 3 | GO:1901524 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.03e-03 | 38 | 108 | 3 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 1.04e-03 | 85 | 108 | 4 | GO:0002762 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.11e-03 | 39 | 108 | 3 | GO:0045717 | |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 1.18e-03 | 88 | 108 | 4 | GO:0006289 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.20e-03 | 40 | 108 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | regulation of chromatin organization | 1.20e-03 | 40 | 108 | 3 | GO:1902275 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.29e-03 | 41 | 108 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 1.37e-03 | 231 | 108 | 6 | GO:0006352 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.38e-03 | 42 | 108 | 3 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of mRNA export from nucleus | 1.45e-03 | 11 | 108 | 2 | GO:0010793 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | TPR EME1 WAPL ERCC6 JADE1 WNK1 TTK WAC USP44 KAT2B ARID2 PRPF19 | 1.57e-03 | 845 | 108 | 12 | GO:0010564 |
| GeneOntologyCellularComponent | chromatin | ZHX3 EME1 TSHZ3 MMS22L EXOSC10 ZEB1 WAPL ERCC6 EP400 FOXP2 ACTR5 SREBF1 SREBF2 POGZ JADE1 ZHX2 USP44 KAT7 KAT2B BRD8 BBX KLF10 TAF9B ARID2 GMEB1 SIX5 MGA HCFC1 | 1.85e-09 | 1480 | 110 | 28 | GO:0000785 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 6.47e-07 | 94 | 110 | 7 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.29e-06 | 104 | 110 | 7 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.77e-06 | 109 | 110 | 7 | GO:1902493 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TPR MMS22L EXOSC10 MIS18BP1 ERCC6 EP400 ACTR5 SCAF8 LIN54 MED14 PHF21A WAC KAT7 GTF2A1 BRD8 TAF9B ARID2 PRPF19 MGA RBM47 HCFC1 | 8.82e-06 | 1377 | 110 | 21 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear chromosome | 6.00e-05 | 254 | 110 | 8 | GO:0000228 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 7.55e-05 | 16 | 110 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.54e-04 | 96 | 110 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | dynein complex | 1.87e-04 | 54 | 110 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | INO80-type complex | 4.22e-04 | 28 | 110 | 3 | GO:0097346 | |
| GeneOntologyCellularComponent | ATPase complex | 6.04e-04 | 129 | 110 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 6.48e-04 | 276 | 110 | 7 | GO:0000775 | |
| GeneOntologyCellularComponent | spindle | 8.63e-04 | 471 | 110 | 9 | GO:0005819 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.09e-03 | 487 | 110 | 9 | GO:0016324 | |
| GeneOntologyCellularComponent | apical part of cell | 1.14e-03 | 592 | 110 | 10 | GO:0045177 | |
| GeneOntologyCellularComponent | nuclear replication fork | 1.40e-03 | 42 | 110 | 3 | GO:0043596 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.71e-03 | 45 | 110 | 3 | GO:1902562 | |
| GeneOntologyCellularComponent | chromosomal region | 1.74e-03 | 421 | 110 | 8 | GO:0098687 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.79e-03 | 98 | 110 | 4 | GO:0060170 | |
| GeneOntologyCellularComponent | Swr1 complex | 2.06e-03 | 13 | 110 | 2 | GO:0000812 | |
| GeneOntologyCellularComponent | A band | 2.60e-03 | 52 | 110 | 3 | GO:0031672 | |
| GeneOntologyCellularComponent | cilium | DYNC2I2 PSG2 PSG4 PSG9 ARFGEF2 JADE1 SHANK2 VPS13A CFAP74 C2CD6 DNAH8 DNAH11 | 2.71e-03 | 898 | 110 | 12 | GO:0005929 |
| Domain | IGc2 | 1.08e-06 | 235 | 108 | 10 | SM00408 | |
| Domain | Ig_sub2 | 1.08e-06 | 235 | 108 | 10 | IPR003598 | |
| Domain | Ig-like_fold | COL6A3 LILRA2 PSG2 PSG4 PSG7 PSG9 IGSF10 LRIG3 HMCN2 SHANK2 TRIM9 PXDNL ATF7IP IL21R MYOM2 HCFC1 | 2.92e-06 | 706 | 108 | 16 | IPR013783 |
| Domain | - | COL6A3 LILRA2 PSG2 PSG4 PSG7 PSG9 IGSF10 LRIG3 TRIM9 PXDNL ATF7IP IL21R MYOM2 HCFC1 | 2.82e-05 | 663 | 108 | 14 | 2.60.40.10 |
| Domain | Ig_2 | 6.47e-05 | 73 | 108 | 5 | PF13895 | |
| Domain | VPS13 | 9.90e-05 | 3 | 108 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 9.90e-05 | 3 | 108 | 2 | PF16910 | |
| Domain | VPS13 | 9.90e-05 | 3 | 108 | 2 | PF16908 | |
| Domain | VPS13_N2 | 9.90e-05 | 3 | 108 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 9.90e-05 | 3 | 108 | 2 | IPR031642 | |
| Domain | IG | 1.65e-04 | 421 | 108 | 10 | SM00409 | |
| Domain | Ig_sub | 1.65e-04 | 421 | 108 | 10 | IPR003599 | |
| Domain | SHR-BD | 1.97e-04 | 4 | 108 | 2 | IPR009543 | |
| Domain | VPS13_C | 1.97e-04 | 4 | 108 | 2 | PF16909 | |
| Domain | VPS13_C | 1.97e-04 | 4 | 108 | 2 | IPR031645 | |
| Domain | SHR-BD | 1.97e-04 | 4 | 108 | 2 | PF06650 | |
| Domain | Autophagy-rel_C | 3.28e-04 | 5 | 108 | 2 | IPR015412 | |
| Domain | ATG_C | 3.28e-04 | 5 | 108 | 2 | PF09333 | |
| Domain | IG_LIKE | 5.58e-04 | 491 | 108 | 10 | PS50835 | |
| Domain | Ig-like_dom | 6.72e-04 | 503 | 108 | 10 | IPR007110 | |
| Domain | Homeodomain-like | 6.91e-04 | 332 | 108 | 8 | IPR009057 | |
| Domain | Ig_I-set | 8.30e-04 | 190 | 108 | 6 | IPR013098 | |
| Domain | I-set | 8.30e-04 | 190 | 108 | 6 | PF07679 | |
| Domain | Chorein_N | 9.07e-04 | 8 | 108 | 2 | PF12624 | |
| Domain | DHC_N1 | 9.07e-04 | 8 | 108 | 2 | PF08385 | |
| Domain | VPS13_N | 9.07e-04 | 8 | 108 | 2 | IPR026854 | |
| Domain | Dynein_heavy_dom-1 | 9.07e-04 | 8 | 108 | 2 | IPR013594 | |
| Domain | FN3 | 1.05e-03 | 199 | 108 | 6 | PS50853 | |
| Domain | FN3_dom | 1.36e-03 | 209 | 108 | 6 | IPR003961 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.88e-03 | 14 | 108 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.88e-03 | 14 | 108 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.88e-03 | 14 | 108 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.88e-03 | 14 | 108 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.88e-03 | 14 | 108 | 2 | IPR011704 | |
| Domain | MT | 2.88e-03 | 14 | 108 | 2 | PF12777 | |
| Domain | AAA_8 | 2.88e-03 | 14 | 108 | 2 | PF12780 | |
| Domain | AAA_5 | 2.88e-03 | 14 | 108 | 2 | PF07728 | |
| Domain | DHC_fam | 3.31e-03 | 15 | 108 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 3.31e-03 | 15 | 108 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.31e-03 | 15 | 108 | 2 | IPR004273 | |
| Domain | FN3 | 4.43e-03 | 185 | 108 | 5 | SM00060 | |
| Domain | ig | 4.95e-03 | 190 | 108 | 5 | PF00047 | |
| Domain | Immunoglobulin | 4.95e-03 | 190 | 108 | 5 | IPR013151 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 9.93e-07 | 272 | 71 | 10 | M29619 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 7.86e-05 | 142 | 71 | 6 | M27233 | |
| Pubmed | ZHX3 TSHZ3 SLK ZEB1 EP400 FOXP2 ACTR5 SCAF8 LIN54 NACA ZMYM2 POGZ PHF8 ZHX2 PHF21A KAT2B BRD8 BBX KLF10 GSE1 TAF9B RBM27 TRIM9 ATF7IP ARID2 GMEB1 SIX5 PRPF19 CABIN1 MGA NOP2 HCFC1 LRIF1 | 7.38e-20 | 1429 | 110 | 33 | 35140242 | |
| Pubmed | ZHX3 EXOSC10 MIS18BP1 EP400 LIN54 ZMYM2 POGZ PHF21A KAT7 GTF2A1 BBX GSE1 TAF9B RBM27 PRPF19 MGA HCFC1 LRIF1 | 3.56e-17 | 339 | 110 | 18 | 30415952 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR ZHX3 EXOSC10 SLK WAPL EP400 RAPH1 RPAP3 NACA ZMYM2 WNK1 PHF21A WAC GTF2A1 GSE1 SYNJ1 RBM27 TRIM9 ATF7IP ARID2 NUMB PRPF19 NOP2 MTDH HCFC1 | 1.62e-16 | 934 | 110 | 25 | 33916271 |
| Pubmed | ZHX3 EXOSC10 WAPL EP400 LIN54 MED14 ZMYM2 PHF21A WAC BRD8 GSE1 TAF9B RBM27 MGA HCFC1 | 8.28e-15 | 268 | 110 | 15 | 33640491 | |
| Pubmed | TPR EXOSC10 SLK WAPL EP400 RAPH1 RPAP3 MED14 POGZ PHF8 BRD8 LATS1 TAF9B SYNJ1 RBM27 ARID2 NUMB MGA HCFC1 | 1.10e-14 | 549 | 110 | 19 | 38280479 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TSHZ3 ZEB1 EP400 FOXP2 LIN54 ZMYM2 POGZ ZHX2 PHF21A KAT2B GSE1 ARID2 MGA PRDM6 LRIF1 | 4.21e-13 | 351 | 110 | 15 | 38297188 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZHX3 TSHZ3 WAPL MIS18BP1 ERCC6 LIN54 ZMYM2 POGZ PHF8 KAT7 BBX ARID2 CABIN1 MGA NOP2 HCFC1 LRIF1 ZNF292 | 8.14e-13 | 608 | 110 | 18 | 36089195 |
| Pubmed | ZHX3 ZEB1 FOXP2 SREBF1 ZMYM2 POGZ JADE1 PHF8 PHF21A KAT7 ZC3H10 GTF2A1 KAT2B BRD8 BBX KLF10 ARID2 GMEB1 MGA ZNF292 | 1.03e-12 | 808 | 110 | 20 | 20412781 | |
| Pubmed | A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. | 2.56e-12 | 14 | 110 | 6 | 10976766 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR ZHX3 EME1 ZEB1 WAPL EP400 RAPH1 SCAF8 MED14 ARFGEF2 ZMYM2 POGZ PHF8 AKT1S1 BRD8 LATS1 GSE1 LIMCH1 NOP2 | 4.66e-12 | 774 | 110 | 19 | 15302935 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | TPR EXOSC10 WAPL EP400 WAC GTF2A1 BBX RBM27 PRPF19 MGA NOP2 MTDH HCFC1 | 6.83e-12 | 283 | 110 | 13 | 30585729 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EME1 EXOSC10 EP400 ACTR5 LIN54 SREBF1 ZMYM2 POGZ PHF8 PHF21A WAC KAT7 BRD8 BBX TAF9B RBM27 PRPF19 CABIN1 MGA NOP2 MTDH HCFC1 LRIF1 | 1.45e-11 | 1294 | 110 | 23 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR ZHX3 EXOSC10 WAPL EP400 LIN54 ZMYM2 POGZ WAC BRD8 BBX TAF9B RBM27 ATF7IP ARID2 PRPF19 MGA NOP2 MTDH HCFC1 | 2.05e-11 | 954 | 110 | 20 | 36373674 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NRBP1 ZHX3 TSHZ3 ZEB1 EP400 POGZ ZHX2 PHF21A SYNJ1 ATF7IP ARID2 SIX5 MGA ZNF292 | 3.57e-11 | 398 | 110 | 14 | 35016035 |
| Pubmed | TPR NRBP1 ERCC6 COBLL1 ZMYM2 WNK1 WAC KAT7 BRD8 KLF10 RBM27 GMEB1 NUMB NOP2 HCFC1 | 6.89e-11 | 503 | 110 | 15 | 16964243 | |
| Pubmed | ZHX3 EXOSC10 EP400 LIN54 MED14 ZMYM2 POGZ PHF21A WAC ZC3H10 ARHGDIB GSE1 RBM27 ARID2 GMEB1 PRPF19 NOP2 HCFC1 LRIF1 ZNF292 | 2.63e-10 | 1103 | 110 | 20 | 34189442 | |
| Pubmed | WAPL ERCC6 EP400 FOXP2 ACTR5 POGZ PHF8 PHF21A KAT7 LRIG3 KAT2B BRD8 HMCN2 GSE1 TAF9B MTUS1 ARID2 IL21R CAPRIN2 MGA | 3.23e-10 | 1116 | 110 | 20 | 31753913 | |
| Pubmed | TPR TSHZ3 ZEB1 RAPH1 RPAP3 LIN54 ZMYM2 POGZ PHF21A GSE1 SYNJ1 ATF7IP MGA | 8.38e-10 | 418 | 110 | 13 | 34709266 | |
| Pubmed | 1.80e-09 | 106 | 110 | 8 | 19394292 | ||
| Pubmed | 2.46e-09 | 222 | 110 | 10 | 37071664 | ||
| Pubmed | 6.57e-09 | 8 | 110 | 4 | 1690992 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 6.69e-09 | 125 | 110 | 8 | 32891193 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.16e-08 | 134 | 110 | 8 | 25452129 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.23e-08 | 341 | 110 | 11 | 32971831 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR WAPL EP400 FOXP2 LIN54 ZMYM2 POGZ PHF21A BRD8 BBX GSE1 SIX5 CABIN1 MGA HCFC1 PRDM6 | 1.30e-08 | 857 | 110 | 16 | 25609649 |
| Pubmed | WAPL EP400 VPS13C NACA AKNA POGZ JADE1 PHF21A LRIG3 MTUS1 RBM27 TRIM9 CAPRIN2 | 1.39e-08 | 529 | 110 | 13 | 14621295 | |
| Pubmed | EME1 SLK MIS18BP1 EP400 MED14 WNK1 KAT7 KAT2B BRD8 BBX RBM27 CABIN1 NOP2 LRIF1 | 1.77e-08 | 645 | 110 | 14 | 25281560 | |
| Pubmed | TPR SYNPO2 COBLL1 SREBF2 ZMYM2 POGZ WNK1 GTF2A1 LATS1 ATF7IP ARID2 MGA | 4.94e-08 | 486 | 110 | 12 | 20936779 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 6.46e-08 | 167 | 110 | 8 | 20362541 | |
| Pubmed | ZHX3 SLK EP400 SCAF8 POGZ PHF8 ZHX2 LRIG3 GSE1 STARD9 LIMCH1 | 7.45e-08 | 407 | 110 | 11 | 12693553 | |
| Pubmed | EME1 RAPH1 LIN54 C2orf78 RYR2 LATS1 BBX SHANK2 STARD9 CSPG4 CAPRIN2 VPS13A PRPF19 CFAP74 MYOM2 LIMCH1 DNAH8 MTDH ZNF292 | 1.29e-07 | 1442 | 110 | 19 | 35575683 | |
| Pubmed | 1.36e-07 | 74 | 110 | 6 | 29795351 | ||
| Pubmed | EXOSC10 EP400 EPB41L4B VPS13C LIN54 ARFGEF2 RYR2 LRIG3 BBX ATF7IP VPS13A MGA NOP2 MTDH | 1.74e-07 | 777 | 110 | 14 | 35844135 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ZHX3 TSHZ3 ZEB1 MIS18BP1 FOXP2 SREBF1 SREBF2 AKNA ZHX2 BBX KLF10 GMEB1 SIX5 MGA MYRF | 1.87e-07 | 908 | 110 | 15 | 19274049 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 2.16e-07 | 357 | 110 | 10 | 37059091 | |
| Pubmed | 2.70e-07 | 83 | 110 | 6 | 28794006 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MIS18BP1 EP400 LIN54 ZMYM2 ZCCHC2 WNK1 TTK GSE1 SYNJ1 ATF7IP ARID2 LRIF1 | 3.81e-07 | 588 | 110 | 12 | 38580884 |
| Pubmed | 4.86e-07 | 390 | 110 | 10 | 17643375 | ||
| Pubmed | 5.44e-07 | 21 | 110 | 4 | 27270040 | ||
| Pubmed | 6.48e-07 | 506 | 110 | 11 | 30890647 | ||
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 1.07e-06 | 7 | 110 | 3 | 7794280 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.56e-06 | 444 | 110 | 10 | 34795231 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.66e-06 | 256 | 110 | 8 | 33397691 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SLK RAPH1 EPB41L4B COBLL1 TTK ARHGDIB SHANK2 SYNJ1 NUMB LIMCH1 HCFC1 | 1.89e-06 | 565 | 110 | 11 | 25468996 |
| Pubmed | TPR SLK RAPH1 ATP13A1 VPS13C TTK RBM27 VPS13A LIMCH1 MTDH HCFC1 | 1.99e-06 | 568 | 110 | 11 | 37774976 | |
| Pubmed | 2.05e-06 | 65 | 110 | 5 | 22496869 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EP400 ATP13A1 SREBF1 MED14 AKNA ARFGEF2 JADE1 WNK1 SHANK2 KLF10 SYNJ1 CSPG4 CABIN1 MYRF HCFC1 | 2.17e-06 | 1105 | 110 | 15 | 35748872 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.74e-06 | 123 | 110 | 6 | 26912792 | |
| Pubmed | 2.88e-06 | 124 | 110 | 6 | 20850016 | ||
| Pubmed | ERCC6 PSG2 PSG9 ARFGEF2 ZMYM2 RYR2 KLF10 ATF7IP CSPG4 GMEB1 MGA | 2.91e-06 | 591 | 110 | 11 | 15231748 | |
| Pubmed | 3.46e-06 | 128 | 110 | 6 | 30995482 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAPH1 COBLL1 WNK1 TTK AKT1S1 LATS1 SYNJ1 MTUS1 TRIM9 STARD9 NUMB LIMCH1 OTOG | 3.49e-06 | 861 | 110 | 13 | 36931259 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 4.10e-06 | 495 | 110 | 10 | 27705803 | |
| Pubmed | 5.99e-06 | 216 | 110 | 7 | 31519766 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZEB1 MIS18BP1 SREBF1 ZMYM2 POGZ WAC GTF2A1 GSE1 ABCB10 RBM27 CSPG4 MGA NOP2 MTDH HCFC1 | 6.05e-06 | 1203 | 110 | 15 | 29180619 |
| Pubmed | SLK WAPL EPB41L4B RPAP3 SCAF8 NACA SREBF1 SREBF2 GSE1 RBM47 HCFC1 | 7.15e-06 | 650 | 110 | 11 | 38777146 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 7.38e-06 | 146 | 110 | 6 | 23892456 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ZEB1 RAPH1 ATP13A1 LIN54 SREBF2 TTK KAT7 BRD8 GSE1 NUMB PRPF19 LIMCH1 NOP2 | 7.54e-06 | 925 | 110 | 13 | 28986522 |
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 8.60e-06 | 13 | 110 | 3 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 8.60e-06 | 13 | 110 | 3 | 1985902 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 10964771 | ||
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 8.60e-06 | 13 | 110 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 8.60e-06 | 13 | 110 | 3 | 16638824 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 20044046 | ||
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 32150576 | ||
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 22469976 | ||
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 8.60e-06 | 13 | 110 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 8.60e-06 | 13 | 110 | 3 | 28035001 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 8.60e-06 | 13 | 110 | 3 | 12832451 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 8.60e-06 | 13 | 110 | 3 | 15316023 | |
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 8.60e-06 | 13 | 110 | 3 | 21670291 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 22162753 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 8.60e-06 | 13 | 110 | 3 | 23935487 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 2702644 | ||
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 8380065 | ||
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 1279194 | ||
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 15331748 | ||
| Pubmed | An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. | 8.60e-06 | 13 | 110 | 3 | 16079794 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 8.60e-06 | 13 | 110 | 3 | 22406619 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 7628460 | ||
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 25724769 | ||
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 26374765 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 8.60e-06 | 13 | 110 | 3 | 25972571 | |
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 8.60e-06 | 13 | 110 | 3 | 22092845 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 11801635 | ||
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 28913658 | ||
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 19008452 | ||
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 8.60e-06 | 13 | 110 | 3 | 15220458 | |
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 8.60e-06 | 13 | 110 | 3 | 8500759 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 8.60e-06 | 13 | 110 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 8.60e-06 | 13 | 110 | 3 | 23800882 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 15207636 | ||
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 19285068 | ||
| Interaction | KLF3 interactions | ZHX3 TSHZ3 ZEB1 EP400 LIN54 ZMYM2 POGZ ZHX2 PHF21A KAT2B GSE1 TAF9B ATF7IP ARID2 MGA LRIF1 | 9.99e-14 | 228 | 109 | 16 | int:KLF3 |
| Interaction | HNF4A interactions | EP400 LIN54 SREBF1 SREBF2 MED14 ZMYM2 POGZ ZHX2 KAT2B BRD8 GSE1 TAF9B ATF7IP ARID2 CABIN1 MGA | 1.79e-12 | 275 | 109 | 16 | int:HNF4A |
| Interaction | NAA40 interactions | TPR ZHX3 EXOSC10 SLK WAPL EP400 RAPH1 RPAP3 NACA ZMYM2 WNK1 PHF21A WAC GTF2A1 GSE1 SYNJ1 RBM27 TRIM9 ATF7IP ARID2 NUMB PRPF19 LIMCH1 NOP2 MTDH HCFC1 | 9.47e-12 | 978 | 109 | 26 | int:NAA40 |
| Interaction | NUP43 interactions | EME1 MIS18BP1 EP400 ACTR5 LIN54 ZMYM2 POGZ PHF8 ZHX2 PHF21A RYR2 USP44 BRD8 BBX GSE1 TAF9B ATF7IP ARID2 MGA HCFC1 ZNF292 | 1.79e-11 | 625 | 109 | 21 | int:NUP43 |
| Interaction | ELF4 interactions | EP400 ACTR5 LIN54 POGZ ZHX2 KAT2B BRD8 ATF7IP ARID2 MGA LRIF1 | 3.08e-11 | 115 | 109 | 11 | int:ELF4 |
| Interaction | YY1 interactions | ZHX3 EP400 FOXP2 ACTR5 LIN54 SREBF1 ZMYM2 POGZ ZHX2 KAT2B BRD8 TAF9B ATF7IP ARID2 CABIN1 MGA HCFC1 LRIF1 | 4.05e-11 | 454 | 109 | 18 | int:YY1 |
| Interaction | KLF8 interactions | ZEB1 EP400 ACTR5 LIN54 ZMYM2 POGZ PHF8 ZHX2 PHF21A KAT2B BRD8 TAF9B ATF7IP ARID2 MGA | 2.89e-10 | 329 | 109 | 15 | int:KLF8 |
| Interaction | H3C1 interactions | TPR MMS22L EXOSC10 WAPL ERCC6 COBLL1 NACA MED14 ZMYM2 POGZ JADE1 PHF8 KAT7 KAT2B BBX ARID2 CABIN1 MGA NOP2 DNAH8 PRDM6 LRIF1 ZNF292 | 4.09e-10 | 901 | 109 | 23 | int:H3C1 |
| Interaction | FEV interactions | ZEB1 EP400 FOXP2 LIN54 POGZ ZHX2 PHF21A GSE1 TAF9B ARID2 SIX5 MGA | 1.05e-09 | 203 | 109 | 12 | int:FEV |
| Interaction | AR interactions | TPR ZHX3 EXOSC10 WAPL EP400 VPS13C LIN54 SREBF1 MED14 ZMYM2 PHF21A WAC KAT7 KAT2B BRD8 GSE1 TAF9B RBM27 ARID2 PRPF19 LIMCH1 MGA HCFC1 | 2.61e-09 | 992 | 109 | 23 | int:AR |
| Interaction | TERF2IP interactions | ZHX3 ZEB1 WAPL EP400 LIN54 ZMYM2 POGZ ZC3H10 BRD8 BBX TAF9B RBM27 ATF7IP MGA HCFC1 LRIF1 ZNF292 | 6.83e-09 | 552 | 109 | 17 | int:TERF2IP |
| Interaction | H3C3 interactions | ZHX3 TSHZ3 MMS22L WAPL MIS18BP1 LIN54 ZMYM2 POGZ PHF8 KAT7 BBX ARID2 MGA NOP2 LRIF1 ZNF292 | 1.01e-08 | 495 | 109 | 16 | int:H3C3 |
| Interaction | CBX3 interactions | ZHX3 ZEB1 WAPL MIS18BP1 EP400 COBLL1 LIN54 ZMYM2 POGZ WAC BBX TAF9B RBM27 ATF7IP ARID2 MGA LRIF1 ZNF292 | 1.11e-08 | 646 | 109 | 18 | int:CBX3 |
| Interaction | PAX6 interactions | TSHZ3 ZEB1 EP400 LIN54 ZMYM2 POGZ ZHX2 PHF21A GSE1 SYNJ1 ARID2 C2CD6 CABIN1 MGA | 1.12e-08 | 366 | 109 | 14 | int:PAX6 |
| Interaction | H2BC8 interactions | ZHX3 EME1 MMS22L EXOSC10 ZEB1 WAPL MIS18BP1 EP400 LIN54 ZMYM2 POGZ KAT7 BRD8 BBX MGA LRIF1 ZNF292 | 1.28e-08 | 576 | 109 | 17 | int:H2BC8 |
| Interaction | ELF1 interactions | 2.76e-08 | 126 | 109 | 9 | int:ELF1 | |
| Interaction | WWTR1 interactions | EXOSC10 SLK ZEB1 WAPL EP400 RAPH1 RPAP3 POGZ LATS1 SYNJ1 RBM27 ARID2 NUMB HCFC1 | 6.61e-08 | 422 | 109 | 14 | int:WWTR1 |
| Interaction | HNF1B interactions | 8.32e-08 | 190 | 109 | 10 | int:HNF1B | |
| Interaction | KLF12 interactions | 1.01e-07 | 194 | 109 | 10 | int:KLF12 | |
| Interaction | H3-3A interactions | ZHX3 TSHZ3 WAPL ERCC6 DYNC2I2 LIN54 ZMYM2 POGZ PHF8 KAT7 KAT2B BBX ARID2 CABIN1 MGA HCFC1 LRIF1 ZNF292 | 1.05e-07 | 749 | 109 | 18 | int:H3-3A |
| Interaction | FHL2 interactions | WAPL EP400 SREBF2 POGZ WNK1 PHF21A BBX MTUS1 RBM27 SIX5 C2CD6 PRDM6 LRIF1 | 2.27e-07 | 396 | 109 | 13 | int:FHL2 |
| Interaction | APEX1 interactions | ZEB1 WAPL EP400 RAPH1 ATP13A1 LIN54 SREBF2 POGZ PHF8 TTK KAT7 BRD8 LATS1 BBX GSE1 ARID2 NUMB PRPF19 CFAP74 LIMCH1 MGA NOP2 ZNF292 | 2.49e-07 | 1271 | 109 | 23 | int:APEX1 |
| Interaction | ELK3 interactions | 2.87e-07 | 120 | 109 | 8 | int:ELK3 | |
| Interaction | SMC5 interactions | TPR ZHX3 EXOSC10 WAPL EP400 LIN54 ZMYM2 POGZ WAC BRD8 BBX TAF9B RBM27 ATF7IP ARID2 PRPF19 MGA NOP2 MTDH HCFC1 | 3.65e-07 | 1000 | 109 | 20 | int:SMC5 |
| Interaction | KLF15 interactions | TSHZ3 EP400 LIN54 POGZ KAT2B BRD8 GSE1 ARID2 GMEB1 MGA ZNF292 | 4.99e-07 | 290 | 109 | 11 | int:KLF15 |
| Interaction | MGA interactions | 7.23e-07 | 240 | 109 | 10 | int:MGA | |
| Interaction | ASF1A interactions | 1.01e-06 | 249 | 109 | 10 | int:ASF1A | |
| Interaction | NFYA interactions | 1.64e-06 | 105 | 109 | 7 | int:NFYA | |
| Interaction | HDAC1 interactions | TPR ZHX3 TSHZ3 ZEB1 ERCC6 EP400 RAPH1 RPAP3 SREBF1 ZMYM2 ZHX2 PHF21A BBX GSE1 SYNJ1 PRPF19 CABIN1 MGA HCFC1 PRDM6 | 1.80e-06 | 1108 | 109 | 20 | int:HDAC1 |
| Interaction | ELF2 interactions | 2.11e-06 | 156 | 109 | 8 | int:ELF2 | |
| Interaction | ZMYM2 interactions | 2.17e-06 | 271 | 109 | 10 | int:ZMYM2 | |
| Interaction | XRCC6 interactions | TPR EXOSC10 ZEB1 WAPL EP400 RPAP3 LIN54 WAC GTF2A1 KAT2B BBX GSE1 RBM27 PRPF19 MGA NOP2 MTDH HCFC1 | 2.34e-06 | 928 | 109 | 18 | int:XRCC6 |
| Interaction | POLR1G interactions | EXOSC10 EP400 RPAP3 LIN54 POGZ PHF8 KAT7 BBX TAF9B ATF7IP MGA NOP2 ZNF292 | 2.42e-06 | 489 | 109 | 13 | int:POLR1G |
| Interaction | SOX5 interactions | 2.80e-06 | 162 | 109 | 8 | int:SOX5 | |
| Interaction | SUMO2 interactions | TPR EME1 EXOSC10 WAPL ERCC6 EP400 NACA ZMYM2 POGZ PHF8 ATF7IP ARID2 NOP2 HCFC1 | 3.69e-06 | 591 | 109 | 14 | int:SUMO2 |
| Interaction | EGR2 interactions | 4.18e-06 | 171 | 109 | 8 | int:EGR2 | |
| Interaction | SP7 interactions | 6.01e-06 | 304 | 109 | 10 | int:SP7 | |
| Interaction | LHX2 interactions | 6.90e-06 | 183 | 109 | 8 | int:LHX2 | |
| Interaction | SNRNP40 interactions | MIS18BP1 EP400 SCAF8 POGZ PHF8 ZHX2 PHF21A WAC GSE1 TAF9B ARID2 PRPF19 MGA MTDH | 8.69e-06 | 637 | 109 | 14 | int:SNRNP40 |
| Interaction | CEBPA interactions | ZHX3 EXOSC10 EP400 LIN54 MED14 ZMYM2 POGZ PHF21A WAC ZC3H10 ARHGDIB GSE1 RBM27 ARID2 GMEB1 PRPF19 NOP2 HCFC1 LRIF1 ZNF292 | 1.03e-05 | 1245 | 109 | 20 | int:CEBPA |
| Interaction | SRF interactions | 1.06e-05 | 139 | 109 | 7 | int:SRF | |
| Interaction | KLF5 interactions | 1.10e-05 | 195 | 109 | 8 | int:KLF5 | |
| Interaction | KLF6 interactions | 1.28e-05 | 95 | 109 | 6 | int:KLF6 | |
| Interaction | SLX4 interactions | EME1 EXOSC10 MIS18BP1 ERCC6 EP400 NACA ZMYM2 POGZ PHF8 ATF7IP MGA HCFC1 LRIF1 | 1.31e-05 | 572 | 109 | 13 | int:SLX4 |
| Interaction | TFCP2L1 interactions | 1.62e-05 | 99 | 109 | 6 | int:TFCP2L1 | |
| Interaction | POU5F1 interactions | TPR EXOSC10 WAPL EP400 SCAF8 NACA ZMYM2 JADE1 KAT7 RBM27 CABIN1 MGA HCFC1 | 1.63e-05 | 584 | 109 | 13 | int:POU5F1 |
| Interaction | MEAF6 interactions | 2.15e-05 | 104 | 109 | 6 | int:MEAF6 | |
| Interaction | TRRAP interactions | WAPL EP400 SCAF8 VPS13C NACA SREBF1 SREBF2 MED14 ZMYM2 KAT2B BRD8 TAF9B MGA NOP2 MTDH | 2.28e-05 | 790 | 109 | 15 | int:TRRAP |
| Interaction | H2BC21 interactions | EME1 MMS22L EP400 ZMYM2 POGZ JADE1 PHF8 KAT7 KAT2B ARID2 NOP2 HCFC1 LRIF1 ZNF292 | 2.33e-05 | 696 | 109 | 14 | int:H2BC21 |
| Interaction | CBX1 interactions | 2.68e-05 | 288 | 109 | 9 | int:CBX1 | |
| Interaction | IKZF5 interactions | 2.69e-05 | 65 | 109 | 5 | int:IKZF5 | |
| Interaction | NFIX interactions | 3.28e-05 | 227 | 109 | 8 | int:NFIX | |
| Interaction | POLR2A interactions | ERCC6 RPAP3 SREBF1 MED14 PHF8 COLQ TTK WAC KAT2B ATF7IP PRPF19 CABIN1 | 3.34e-05 | 536 | 109 | 12 | int:POLR2A |
| Interaction | MEN1 interactions | ZHX3 EXOSC10 WAPL ERCC6 EP400 MED14 ZMYM2 POGZ PHF8 WAC KAT7 GSE1 ARID2 PRPF19 NOP2 MTDH HCFC1 | 3.68e-05 | 1029 | 109 | 17 | int:MEN1 |
| Interaction | NPHP4 interactions | 4.32e-05 | 236 | 109 | 8 | int:NPHP4 | |
| Interaction | DYNLT1 interactions | 5.01e-05 | 241 | 109 | 8 | int:DYNLT1 | |
| Interaction | NFYC interactions | 5.02e-05 | 177 | 109 | 7 | int:NFYC | |
| Interaction | SMAD1 interactions | 5.31e-05 | 243 | 109 | 8 | int:SMAD1 | |
| Interaction | LRIF1 interactions | 5.95e-05 | 247 | 109 | 8 | int:LRIF1 | |
| Interaction | CRX interactions | 7.24e-05 | 254 | 109 | 8 | int:CRX | |
| Interaction | TAF1 interactions | 8.52e-05 | 260 | 109 | 8 | int:TAF1 | |
| Interaction | MYB interactions | 8.57e-05 | 133 | 109 | 6 | int:MYB | |
| Interaction | TFDP1 interactions | 8.57e-05 | 133 | 109 | 6 | int:TFDP1 | |
| Interaction | ARL16 interactions | 8.76e-05 | 83 | 109 | 5 | int:ARL16 | |
| Interaction | TULP3 interactions | 1.10e-04 | 346 | 109 | 9 | int:TULP3 | |
| Interaction | ZSWIM9 interactions | 1.18e-04 | 18 | 109 | 3 | int:ZSWIM9 | |
| Interaction | POLR1E interactions | 1.20e-04 | 350 | 109 | 9 | int:POLR1E | |
| Interaction | CSNK2B interactions | NRBP1 ZHX3 ERCC6 EP400 ACTR5 ARFGEF2 POGZ JADE1 PHF8 ZHX2 KAT7 HCFC1 | 1.44e-04 | 625 | 109 | 12 | int:CSNK2B |
| Interaction | MPHOSPH8 interactions | 1.50e-04 | 93 | 109 | 5 | int:MPHOSPH8 | |
| Interaction | KDM1A interactions | TPR TSHZ3 ZEB1 EP400 RAPH1 RPAP3 LIN54 ZMYM2 POGZ PHF8 PHF21A GSE1 SYNJ1 ATF7IP MGA | 1.64e-04 | 941 | 109 | 15 | int:KDM1A |
| Interaction | SP1 interactions | 1.65e-04 | 365 | 109 | 9 | int:SP1 | |
| Interaction | SLC19A4P interactions | 1.73e-04 | 4 | 109 | 2 | int:SLC19A4P | |
| Interaction | KLF13 interactions | 1.91e-04 | 21 | 109 | 3 | int:KLF13 | |
| Interaction | ADNP2 interactions | 2.08e-04 | 54 | 109 | 4 | int:ADNP2 | |
| Interaction | CENPA interactions | 2.10e-04 | 377 | 109 | 9 | int:CENPA | |
| Interaction | PSG3 interactions | 2.20e-04 | 22 | 109 | 3 | int:PSG3 | |
| Interaction | PRR20E interactions | 2.21e-04 | 101 | 109 | 5 | int:PRR20E | |
| Interaction | HDAC2 interactions | ZHX3 ZEB1 ERCC6 EP400 ZMYM2 ZHX2 WNK1 PHF21A KAT2B GSE1 NUMB CABIN1 HCFC1 PRDM6 | 2.35e-04 | 865 | 109 | 14 | int:HDAC2 |
| Interaction | LHX1 interactions | 2.43e-04 | 103 | 109 | 5 | int:LHX1 | |
| Interaction | CDH1 interactions | SLK ZEB1 RAPH1 EPB41L4B COBLL1 TTK ARHGDIB SHANK2 SYNJ1 PTPRQ NUMB LIMCH1 HCFC1 | 2.60e-04 | 768 | 109 | 13 | int:CDH1 |
| Interaction | YAP1 interactions | TPR EXOSC10 SLK ZEB1 WAPL RPAP3 MED14 POGZ PHF8 BRD8 LATS1 TAF9B ARID2 NUMB MGA HCFC1 | 2.62e-04 | 1095 | 109 | 16 | int:YAP1 |
| Interaction | L3MBTL2 interactions | 2.63e-04 | 231 | 109 | 7 | int:L3MBTL2 | |
| Interaction | ZNF280D interactions | 2.87e-04 | 24 | 109 | 3 | int:ZNF280D | |
| Interaction | TAF7 interactions | 3.02e-04 | 108 | 109 | 5 | int:TAF7 | |
| Interaction | PPIA interactions | ZHX3 MMS22L ERCC6 EP400 RAPH1 EPB41L4B NACA GTF2A1 BBX STARD9 ARID2 NUMB PRPF19 HCFC1 | 3.07e-04 | 888 | 109 | 14 | int:PPIA |
| Interaction | ATXN7L2 interactions | 3.13e-04 | 60 | 109 | 4 | int:ATXN7L2 | |
| Interaction | PRR20A interactions | 3.15e-04 | 109 | 109 | 5 | int:PRR20A | |
| Interaction | KAT14 interactions | 3.58e-04 | 112 | 109 | 5 | int:KAT14 | |
| Interaction | H2BC3 interactions | 3.62e-04 | 406 | 109 | 9 | int:H2BC3 | |
| Interaction | ACTC1 interactions | TPR ZHX3 EP400 RAPH1 COBLL1 TTK WAC BRD8 SYNJ1 TRIM9 ARID2 NOP2 | 3.75e-04 | 694 | 109 | 12 | int:ACTC1 |
| Interaction | ING5 interactions | 3.88e-04 | 114 | 109 | 5 | int:ING5 | |
| Interaction | TEAD1 interactions | 3.92e-04 | 176 | 109 | 6 | int:TEAD1 | |
| Interaction | CREBBP interactions | ZEB1 SREBF1 SREBF2 ZMYM2 JADE1 KAT2B LATS1 ATF7IP GMEB1 MGA MTDH | 4.02e-04 | 599 | 109 | 11 | int:CREBBP |
| Interaction | H2AC4 interactions | 4.21e-04 | 506 | 109 | 10 | int:H2AC4 | |
| Interaction | NPY2R interactions | 4.51e-04 | 66 | 109 | 4 | int:NPY2R | |
| Interaction | PHLPP1 interactions | 4.57e-04 | 333 | 109 | 8 | int:PHLPP1 | |
| Interaction | DCAF15 interactions | 4.76e-04 | 255 | 109 | 7 | int:DCAF15 | |
| Interaction | EPC2 interactions | 4.78e-04 | 67 | 109 | 4 | int:EPC2 | |
| Interaction | KLF16 interactions | 5.03e-04 | 425 | 109 | 9 | int:KLF16 | |
| Interaction | PML interactions | EME1 ERCC6 EP400 RPAP3 LIN54 ZMYM2 ZHX2 PHF21A BRD8 KLF10 ATF7IP NOP2 MTDH HCFC1 | 5.04e-04 | 933 | 109 | 14 | int:PML |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 9.30e-08 | 11 | 76 | 4 | 1315 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.80e-07 | 15 | 76 | 4 | 529 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.84e-04 | 161 | 76 | 5 | 593 | |
| GeneFamily | ATAC complex | 1.32e-03 | 13 | 76 | 2 | 1058 | |
| GeneFamily | Dyneins, axonemal | 2.28e-03 | 17 | 76 | 2 | 536 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.28e-03 | 17 | 76 | 2 | 486 | |
| GeneFamily | Fibronectin type III domain containing | 4.62e-03 | 160 | 76 | 4 | 555 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 4.91e-03 | 25 | 76 | 2 | 775 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZHX3 SLK WAPL SCAF8 ZMYM2 ZHX2 PHF21A BBX KLF10 VPS13A NUMB LIMCH1 ZNF292 | 7.45e-08 | 466 | 109 | 13 | M13522 |
| Coexpression | GABRIELY_MIR21_TARGETS | RAPH1 COBLL1 ZMYM2 WNK1 GTF2A1 LATS1 VPS13A LIMCH1 MGA ZNF292 | 3.71e-07 | 289 | 109 | 10 | M2196 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZHX3 SLK ZEB1 WAPL SCAF8 ZMYM2 PHF8 ZHX2 TTK PHF21A BBX KLF10 GSE1 VPS13A NUMB ZNF292 | 5.10e-07 | 856 | 109 | 16 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR SLK ZEB1 WAPL MIS18BP1 EP400 SCAF8 VPS13C AKNA JADE1 WNK1 WAC ARHGDIB KAT2B LATS1 BBX RBM27 ATF7IP ARID2 MTDH ZNF292 | 7.75e-07 | 1492 | 109 | 21 | M40023 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | SLK WAPL PSG4 PSG7 PSG9 ARFGEF2 ZHX2 WAC KLF10 GSE1 MTUS1 ATF7IP GMEB1 NUMB LRIF1 | 1.61e-06 | 822 | 109 | 15 | M6782 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ZHX3 TSHZ3 SLK MIS18BP1 RAPH1 VPS13C COBLL1 SREBF1 ARFGEF2 WAC KAT2B BBX KLF10 GSE1 TRIM9 ZNF292 | 1.88e-06 | 946 | 109 | 16 | M39169 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SLK MIS18BP1 RPAP3 VPS13C ZCCHC2 COLQ TTK BBX MTUS1 RBM27 ATF7IP CAPRIN2 MTDH | 3.47e-06 | 656 | 109 | 13 | M18979 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.06e-05 | 180 | 109 | 7 | M8239 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | EME1 MIS18BP1 ERCC6 RPAP3 VPS13C COBLL1 JADE1 TTK KAT2B KLF10 ABCB10 TAF9B LIMCH1 MTDH | 2.02e-05 | 892 | 109 | 14 | M18120 |
| Coexpression | GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN | 2.03e-05 | 199 | 109 | 7 | M3517 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | EPB41L4B VPS13C ZMYM2 POGZ LRIG3 KAT2B LATS1 BBX SHANK2 ATF7IP ARID2 LIMCH1 CABIN1 | 3.12e-05 | 807 | 109 | 13 | M16651 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 3.75e-05 | 300 | 109 | 8 | M8702 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 5.48e-05 | 159 | 109 | 6 | MM760 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 6.85e-05 | 102 | 109 | 5 | M10290 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 6.97e-05 | 166 | 109 | 6 | M344 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 7.69e-05 | 169 | 109 | 6 | M39230 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 7.80e-05 | 429 | 109 | 9 | M29 | |
| Coexpression | GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN | 9.32e-05 | 175 | 109 | 6 | M2940 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN | 1.46e-04 | 190 | 109 | 6 | M7317 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN | 1.78e-04 | 197 | 109 | 6 | M3438 | |
| Coexpression | GSE3982_MAST_CELL_VS_NEUTROPHIL_DN | 1.78e-04 | 197 | 109 | 6 | M5433 | |
| Coexpression | GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN | 1.83e-04 | 198 | 109 | 6 | M9346 | |
| Coexpression | WHITFIELD_CELL_CYCLE_G2_M | 1.83e-04 | 198 | 109 | 6 | M2077 | |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 1.88e-04 | 199 | 109 | 6 | M8381 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH1_UP | 1.88e-04 | 199 | 109 | 6 | M5564 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 1.93e-04 | 200 | 109 | 6 | M5063 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 1.93e-04 | 200 | 109 | 6 | M8030 | |
| Coexpression | GSE27786_BCELL_VS_NKTCELL_DN | 1.93e-04 | 200 | 109 | 6 | M4809 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN | 1.93e-04 | 200 | 109 | 6 | M4041 | |
| Coexpression | GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP | 1.93e-04 | 200 | 109 | 6 | M9542 | |
| Coexpression | GSE360_DC_VS_MAC_L_DONOVANI_DN | 1.93e-04 | 200 | 109 | 6 | M5176 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_CULTURE_DN | 1.93e-04 | 200 | 109 | 6 | M7293 | |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN | 1.93e-04 | 200 | 109 | 6 | M9765 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN | 1.93e-04 | 200 | 109 | 6 | M3841 | |
| Coexpression | GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN | 1.93e-04 | 200 | 109 | 6 | M6062 | |
| Coexpression | GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP | 1.93e-04 | 200 | 109 | 6 | M5623 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | SLK RAPH1 EPB41L4B PSG4 VPS13C MFSD6 ARFGEF2 LRIG3 KAT2B MTUS1 LIMCH1 | 2.24e-04 | 726 | 109 | 11 | M4210 |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_DN | 2.60e-04 | 74 | 109 | 4 | M42506 | |
| Coexpression | GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP | 2.74e-04 | 137 | 109 | 5 | M460 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 2.74e-04 | 75 | 109 | 4 | MM605 | |
| Coexpression | KRIEG_HYPOXIA_NOT_VIA_KDM3A | TSHZ3 RAPH1 PSG7 ZMYM2 ZHX2 PHF21A WAC KAT2B SHANK2 MTUS1 ZNF292 | 2.82e-04 | 746 | 109 | 11 | M2469 |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 3.18e-04 | 32 | 109 | 3 | MM2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPR EME1 MMS22L ZEB1 WAPL MIS18BP1 FOXP2 LIN54 MED14 ARFGEF2 ZMYM2 POGZ SLC35F1 COLQ TTK WAC GTF2A1 SHANK2 RBM27 VPS13A CFAP74 MTDH LRIF1 ZNF292 | 2.14e-08 | 1257 | 110 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | TPR EME1 EXOSC10 SLK ZEB1 RAPH1 RPAP3 MED14 ARFGEF2 WNK1 WAC ARID2 PRPF19 CFAP74 MTDH ZNF292 | 3.46e-08 | 564 | 110 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPR EME1 MMS22L ZEB1 WAPL MIS18BP1 FOXP2 LIN54 MED14 ARFGEF2 ZMYM2 POGZ SLC35F1 COLQ TTK WAC GTF2A1 SHANK2 RBM27 VPS13A CFAP74 MTDH LRIF1 ZNF292 | 3.44e-07 | 1459 | 110 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TPR COL6A3 EME1 SYNPO2 WAPL MIS18BP1 EPB41L4B ARFGEF2 TTK PHF21A WAC IGSF10 ARHGDIB SH3RF2 STARD9 LIMCH1 | 1.43e-06 | 744 | 110 | 16 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | TPR SLK MIS18BP1 ERCC6 FOXP2 MFSD6 ARFGEF2 ZMYM2 WNK1 WAC BBX SH3RF2 NUMB CFAP74 LIMCH1 MGA LRIF1 ZNF292 | 3.16e-06 | 989 | 110 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TPR SLK MIS18BP1 FOXP2 ARFGEF2 ZMYM2 WNK1 WAC NUMB MGA ZNF292 | 1.52e-05 | 432 | 110 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | EME1 WAPL ERCC6 RPAP3 VPS13C JADE1 ZHX2 TTK GTF2A1 BRD8 BBX RBM27 | 2.05e-05 | 532 | 110 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.52e-05 | 298 | 110 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | EME1 EXOSC10 WAPL MIS18BP1 RAPH1 TTK WAC GTF2A1 BBX CFAP74 ZNF292 | 3.24e-05 | 469 | 110 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | TPR EME1 SYNPO2 ZEB1 MIS18BP1 FOXP2 LIN54 ARFGEF2 ZMYM2 COLQ TTK WAC IGSF10 LRIG3 GTF2A1 SH3RF2 ARID2 PRPF19 LRIF1 ZNF292 | 5.95e-05 | 1468 | 110 | 20 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | TPR EME1 ZEB1 MIS18BP1 FOXP2 LIN54 ARFGEF2 ZMYM2 COLQ TTK WAC IGSF10 LRIG3 GTF2A1 ARID2 PRPF19 LRIF1 ZNF292 | 6.64e-05 | 1241 | 110 | 18 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | TPR EME1 MIS18BP1 RPAP3 COBLL1 ZMYM2 POGZ JADE1 SLC35F1 TTK WAC GTF2A1 BBX SHANK2 CAPRIN2 MGA NOP2 MYRF LRIF1 | 7.47e-05 | 1371 | 110 | 19 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | MMS22L WAPL MIS18BP1 ERCC6 RPAP3 ARFGEF2 JADE1 TTK RBM27 CAPRIN2 VPS13A RBM47 DNAH8 HCFC1 | 8.90e-05 | 822 | 110 | 14 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 9.12e-05 | 203 | 110 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TPR EME1 ZEB1 WAPL MIS18BP1 FOXP2 LIN54 ZMYM2 SLC35F1 COLQ WAC CAPRIN2 VPS13A CFAP74 LRIF1 ZNF292 | 1.12e-04 | 1060 | 110 | 16 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | TPR COL6A3 EXOSC10 MIS18BP1 RAPH1 FOXP2 IGSF10 SH3RF2 CSPG4 CFAP74 LIMCH1 LRIF1 | 1.50e-04 | 655 | 110 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | TPR COL6A3 EME1 WAPL MIS18BP1 COBLL1 ARFGEF2 TTK AKT1S1 WAC HMCN2 CFAP74 LIMCH1 RBM47 LRIF1 | 1.58e-04 | 979 | 110 | 15 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | NRBP1 MIS18BP1 COBLL1 MCF2 WNK1 RYR2 BBX SYNJ1 MTUS1 TRIM9 GMEB1 MGA DNAH8 | 1.76e-04 | 770 | 110 | 13 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#3_top-relative-expression-ranked_500 | 3.21e-04 | 63 | 110 | 4 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | MMS22L MIS18BP1 ERCC6 ARFGEF2 PHF8 TTK TAF9B RBM27 CAPRIN2 VPS13A MGA DNAH8 HCFC1 | 3.24e-04 | 820 | 110 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 4.24e-04 | 629 | 110 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.54e-08 | 199 | 110 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-07 | 179 | 110 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.10e-07 | 186 | 110 | 7 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-07 | 188 | 110 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-07 | 188 | 110 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-07 | 188 | 110 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.90e-07 | 191 | 110 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.87e-06 | 175 | 110 | 6 | 6751ee4b312d7f87275f2c35e5878cfc3be3ebe3 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 176 | 110 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.20e-06 | 177 | 110 | 6 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 184 | 110 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.49e-06 | 184 | 110 | 6 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 184 | 110 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 184 | 110 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 6.70e-06 | 185 | 110 | 6 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 6.70e-06 | 185 | 110 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.70e-06 | 185 | 110 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.90e-06 | 186 | 110 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.12e-06 | 187 | 110 | 6 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.12e-06 | 187 | 110 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-06 | 187 | 110 | 6 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-06 | 187 | 110 | 6 | 958402fcc78f4c7a7d13d659d776f3817137975f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-06 | 188 | 110 | 6 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.34e-06 | 188 | 110 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.34e-06 | 188 | 110 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.57e-06 | 189 | 110 | 6 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-06 | 189 | 110 | 6 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 7.57e-06 | 189 | 110 | 6 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 7.57e-06 | 189 | 110 | 6 | f4865b7db16de15120504147a8016ac522ad242a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.80e-06 | 190 | 110 | 6 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.80e-06 | 190 | 110 | 6 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.03e-06 | 191 | 110 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.28e-06 | 192 | 110 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.28e-06 | 192 | 110 | 6 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.28e-06 | 192 | 110 | 6 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.28e-06 | 192 | 110 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.53e-06 | 193 | 110 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 194 | 110 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 9.31e-06 | 196 | 110 | 6 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.58e-06 | 197 | 110 | 6 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.86e-06 | 198 | 110 | 6 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.86e-06 | 198 | 110 | 6 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-05 | 199 | 110 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 199 | 110 | 6 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 139 | 110 | 5 | c9bf98bed77415a1438f3f9e441a1346e75c26b0 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.90e-05 | 71 | 110 | 4 | 7623b110bc3db0f5b99803c8fbb881ae8846b817 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.91e-05 | 153 | 110 | 5 | d7635f3d4831c02a94f53afc674847d5b51453be | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.91e-05 | 153 | 110 | 5 | 54a941950bbb848077c7bd5726da9e4b3244bd38 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.91e-05 | 153 | 110 | 5 | 69a8550418ba0fc908a84b3b85761abb6e8ca4c0 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.91e-05 | 153 | 110 | 5 | e50d20f9e553b8c3e10e187770d8abe1a43d109e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-05 | 157 | 110 | 5 | 2c5295043611bac7dfa4aef2146681bce4a33a8f | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 4.84e-05 | 160 | 110 | 5 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 4.84e-05 | 160 | 110 | 5 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 4.84e-05 | 160 | 110 | 5 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.60e-05 | 165 | 110 | 5 | 9de841c1c95967c562720feba930246debc626fd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.60e-05 | 165 | 110 | 5 | a612a7d3a5415ecacc3df8fbff0ce498f982aad0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.60e-05 | 165 | 110 | 5 | cdc94a640ec01c6892521bcd6f0ee0a66ff23866 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.45e-05 | 170 | 110 | 5 | a0d6466e00bd3dc07f644ba3f87d5b421fd479d5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.82e-05 | 172 | 110 | 5 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.82e-05 | 172 | 110 | 5 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 175 | 110 | 5 | d8e385320f554d974538b7cdc4f8e4767f1455f2 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.40e-05 | 175 | 110 | 5 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 175 | 110 | 5 | cf15465855602ba135752c18755e3e058dbd42ec | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 7.60e-05 | 176 | 110 | 5 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.60e-05 | 176 | 110 | 5 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 177 | 110 | 5 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 177 | 110 | 5 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-05 | 177 | 110 | 5 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.02e-05 | 178 | 110 | 5 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.23e-05 | 179 | 110 | 5 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.45e-05 | 180 | 110 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.67e-05 | 181 | 110 | 5 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.67e-05 | 181 | 110 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.67e-05 | 181 | 110 | 5 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.67e-05 | 181 | 110 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-05 | 182 | 110 | 5 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-05 | 182 | 110 | 5 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-05 | 182 | 110 | 5 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.13e-05 | 183 | 110 | 5 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 9.13e-05 | 183 | 110 | 5 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.37e-05 | 184 | 110 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 9.37e-05 | 184 | 110 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.37e-05 | 184 | 110 | 5 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 9.37e-05 | 184 | 110 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.37e-05 | 184 | 110 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.37e-05 | 184 | 110 | 5 | 590fb32bb1f348ea5fa2aece30ebe1e212512991 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.61e-05 | 185 | 110 | 5 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.61e-05 | 185 | 110 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 9.61e-05 | 185 | 110 | 5 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.61e-05 | 185 | 110 | 5 | 355b03c7ea438681e11a2b872c798c9ea26e1486 | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 9.61e-05 | 185 | 110 | 5 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.86e-05 | 186 | 110 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 9.86e-05 | 186 | 110 | 5 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.86e-05 | 186 | 110 | 5 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.86e-05 | 186 | 110 | 5 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.86e-05 | 186 | 110 | 5 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.86e-05 | 186 | 110 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 187 | 110 | 5 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.01e-04 | 187 | 110 | 5 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| Computational | Neighborhood of CDKN1C | 2.73e-05 | 27 | 71 | 4 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 5.47e-05 | 32 | 71 | 4 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 7.84e-05 | 35 | 71 | 4 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 1.62e-04 | 42 | 71 | 4 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 2.31e-04 | 46 | 71 | 4 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 2.96e-04 | 49 | 71 | 4 | GNF2_KISS1 | |
| Computational | Neighborhood of ATRX | 5.22e-04 | 215 | 71 | 7 | MORF_ATRX | |
| Computational | Neighborhood of PSMF1 | 7.99e-04 | 167 | 71 | 6 | MORF_PSMF1 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.54e-07 | 182 | 110 | 9 | 3887_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; PC3; HT_HG-U133A | 5.66e-06 | 199 | 110 | 8 | 5096_DN | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.29e-05 | 160 | 110 | 7 | 4404_UP | |
| Drug | Sp 1 (pharmaceutical) | LILRA2 ZEB1 PSG9 MED14 POGZ PHF21A KAT7 GTF2A1 KAT2B KLF10 NOP2 HCFC1 | 1.39e-05 | 548 | 110 | 12 | CID000099040 |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.40e-05 | 162 | 110 | 7 | 7340_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.51e-05 | 164 | 110 | 7 | 3963_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.57e-05 | 165 | 110 | 7 | 3851_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.70e-05 | 167 | 110 | 7 | 6047_UP | |
| Drug | Antigens, Polyomavirus Transforming | TSHZ3 MMS22L EXOSC10 MIS18BP1 NACA POGZ WNK1 KAT2B SYNJ1 ARID2 NUMB HCFC1 ZNF292 | 2.07e-05 | 668 | 110 | 13 | ctd:D000952 |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 3.06e-05 | 183 | 110 | 7 | 7498_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.17e-05 | 184 | 110 | 7 | 2321_DN | |
| Drug | Oxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HG-U133A | 4.59e-05 | 195 | 110 | 7 | 1903_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 3748_DN | |
| Drug | Napelline [5008-52-6]; Up 200; 11.2uM; HL60; HT_HG-U133A | 4.90e-05 | 197 | 110 | 7 | 2522_UP | |
| Drug | Trapidil [15421-84-8]; Up 200; 19.4uM; MCF7; HT_HG-U133A | 5.05e-05 | 198 | 110 | 7 | 7475_UP | |
| Drug | AC1L1IPV | 5.50e-05 | 43 | 110 | 4 | CID000004683 | |
| Disease | cD177 antigen measurement | 5.18e-07 | 18 | 109 | 4 | EFO_0021866 | |
| Disease | lipid storage disease (biomarker_via_orthology) | 1.35e-05 | 2 | 109 | 2 | DOID:9455 (biomarker_via_orthology) | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 1.35e-05 | 2 | 109 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 1.35e-05 | 2 | 109 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 4.05e-05 | 3 | 109 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 4.05e-05 | 3 | 109 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 8.07e-05 | 4 | 109 | 2 | EFO_0801909 | |
| Disease | response to carbamazepine | 8.07e-05 | 4 | 109 | 2 | EFO_0008484 | |
| Disease | lysophosphatidylcholine 22:0 measurement | 1.34e-04 | 5 | 109 | 2 | EFO_0021459 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 2.01e-04 | 6 | 109 | 2 | EFO_0801907 | |
| Disease | Manic | 2.04e-04 | 78 | 109 | 4 | C0338831 | |
| Disease | mean corpuscular hemoglobin concentration | ZHX3 SLK EP400 ACTRT3 COBLL1 LIN54 ARFGEF2 GTF2A1 KAT2B VPS13A MYRF MTDH LRIF1 | 2.23e-04 | 1105 | 109 | 13 | EFO_0004528 |
| Disease | Colorectal Carcinoma | 2.80e-04 | 702 | 109 | 10 | C0009402 | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 2.81e-04 | 7 | 109 | 2 | EFO_0801906 | |
| Disease | JT interval | 3.26e-04 | 248 | 109 | 6 | EFO_0007885 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 3.73e-04 | 8 | 109 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Antihypertensive use measurement | 4.64e-04 | 265 | 109 | 6 | EFO_0009927 | |
| Disease | sleep duration, triglyceride measurement | 6.10e-04 | 104 | 109 | 4 | EFO_0004530, EFO_0005271 | |
| Disease | Microphthalmos | 7.28e-04 | 11 | 109 | 2 | C0026010 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 8.71e-04 | 12 | 109 | 2 | C0023485 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 1.18e-03 | 56 | 109 | 3 | EFO_0022250 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.24e-03 | 57 | 109 | 3 | EFO_0022284 | |
| Disease | Insulin Resistance | 1.44e-03 | 60 | 109 | 3 | C0021655 | |
| Disease | Insulin Sensitivity | 1.44e-03 | 60 | 109 | 3 | C0920563 | |
| Disease | phosphatidylcholine 38:3 measurement | 1.57e-03 | 16 | 109 | 2 | EFO_0010385 | |
| Disease | red blood cell density measurement | 1.58e-03 | 880 | 109 | 10 | EFO_0007978 | |
| Disease | lysophosphatidylcholine measurement | 1.58e-03 | 62 | 109 | 3 | EFO_0010224 | |
| Disease | C-reactive protein measurement | MMS22L ZEB1 VPS13C COBLL1 ZCCHC2 PHF21A USP44 LATS1 KLF10 NUMB PLTP DNAH11 | 1.68e-03 | 1206 | 109 | 12 | EFO_0004458 |
| Disease | sporadic amyotrophic lateral sclerosis | 1.84e-03 | 140 | 109 | 4 | EFO_0001357 | |
| Disease | fatty acid measurement, linoleic acid measurement | 2.06e-03 | 68 | 109 | 3 | EFO_0005110, EFO_0006807 | |
| Disease | urate measurement, bone density | 2.13e-03 | 619 | 109 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 2.22e-03 | 19 | 109 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | IGF-1 measurement | 2.27e-03 | 488 | 109 | 7 | EFO_0004627 | |
| Disease | resting heart rate | 2.30e-03 | 149 | 109 | 4 | EFO_0004351 | |
| Disease | calcium measurement | 2.33e-03 | 628 | 109 | 8 | EFO_0004838 | |
| Disease | Manic Disorder | 2.34e-03 | 71 | 109 | 3 | C0024713 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.48e-03 | 152 | 109 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in large LDL percentage | 2.63e-03 | 74 | 109 | 3 | EFO_0022280 | |
| Disease | kidney disease (biomarker_via_orthology) | 2.71e-03 | 21 | 109 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | mean reticulocyte volume | 2.87e-03 | 799 | 109 | 9 | EFO_0010701 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 3.05e-03 | 78 | 109 | 3 | EFO_0022187 | |
| Disease | Depression, Bipolar | 3.16e-03 | 79 | 109 | 3 | C0005587 | |
| Disease | Dyslipidemias | 3.54e-03 | 24 | 109 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 3.54e-03 | 24 | 109 | 2 | C0598784 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTAVTIEVEPSPVQQ | 36 | Q6ZRG5 | |
| FQIVKSVTIPRPTPQ | 521 | Q68DN1 | |
| TGTPVAIATQLPPKV | 456 | Q96L91 | |
| PTQQYAKSLPVSVPV | 176 | Q96B36 | |
| KNIPSIFNTPEPTTT | 801 | Q8WY36 | |
| AFTVTVLPVNDQPPI | 1461 | Q6UVK1 | |
| KEVQPTNVLPPVSTS | 251 | A6NCI8 | |
| LVPPPVESVSQATIV | 296 | Q9H0E9 | |
| KVAPANTAVQVIAPP | 316 | Q9BYD9 | |
| PSKATFVKVVPTPNN | 136 | Q9HD20 | |
| PPVVTIAPTKTVNGV | 121 | Q14687 | |
| PQSPVIQAAAVSPKF | 216 | Q9Y6D5 | |
| QNAPVTVIQSKAPIP | 696 | Q68CP9 | |
| IAPKPLPSQQVSSTV | 896 | Q68CP9 | |
| KAFPNPPIAVTNVTA | 3206 | Q96DT5 | |
| SPNLATFVLSVVPPV | 311 | Q9NRK6 | |
| PGVEKPVTTVQPVFN | 421 | Q9H9F9 | |
| IAPKPVTIPASQVST | 951 | Q53SF7 | |
| VPPSKVVEFEVSPQS | 161 | O95156 | |
| PPVPVSINSNITRVV | 541 | Q9P2N5 | |
| IPTVNPVAIKPGTVA | 431 | A0AV96 | |
| TKTVAPVVTQAAPPT | 791 | Q70E73 | |
| SPVPSVVKQIASQFP | 856 | Q70E73 | |
| LSVQPVPTVAPGKNV | 326 | Q8N149 | |
| SAIVIQPPENATAPV | 491 | P0DP91 | |
| VVATVVVQPPPPTQS | 1566 | P51610 | |
| APSNTFVAPQPVVVA | 1756 | P51610 | |
| FVAPQPVVVASPAKL | 1761 | P51610 | |
| PSSPRVPVIFVVNNQ | 311 | Q9Y215 | |
| RVTRSQQQPTPVTPK | 76 | O95251 | |
| PLQQAKPVVVNTTPV | 386 | Q6MZP7 | |
| VPKPINPTSQIVTTS | 416 | Q6MZP7 | |
| NPTTPSSVIFPLVKT | 1021 | Q6P0N0 | |
| NTQSLPVTVKSPVLP | 166 | Q5T3J3 | |
| PVQQPQFTVISPITI | 396 | Q9Y692 | |
| QFTVISPITITPVGQ | 401 | Q9Y692 | |
| AQIPVATPQVSPNTV | 1741 | Q8IWI9 | |
| IQTVINPPPVAGTIS | 381 | Q92831 | |
| VTAITPAPIQQPVKS | 486 | O95835 | |
| PVLEPTKVTFSVSPI | 431 | Q9ULD2 | |
| FPKPQITVQPETQSA | 496 | Q6UXM1 | |
| TAPSDFQPQPVISII | 756 | Q6ZRQ5 | |
| LTVQVPPTFENPKTE | 3126 | Q8NDA2 | |
| PPTFENPKTETVSQV | 3131 | Q8NDA2 | |
| TSPQLINTTAKVPVP | 1981 | Q5HYC2 | |
| RPQQPSAVVEVPSAV | 206 | Q96EX3 | |
| PVTKVITPQTVEYPA | 276 | Q53TS8 | |
| VTASVTIALVPPDQP | 346 | P55058 | |
| QQQIRPIKSVIPSPT | 926 | Q96JB1 | |
| PSVITPASVPNVGAI | 461 | O15409 | |
| TVTLVQATPPQPIKV | 201 | Q96BD5 | |
| VPSSPVPIATIDLVQ | 641 | Q6ZSS7 | |
| QKTSVPPQEPVSIIV | 1371 | O60244 | |
| QQEEVTSPVVPPSVK | 416 | Q9UHY1 | |
| PVTRIVTTNVTKPGP | 86 | Q9UMZ3 | |
| TLPETVPSVPTNIAF | 1466 | Q9UMZ3 | |
| APTTQQRSVVFPQTP | 411 | Q9NQX0 | |
| IVPQAVPSSQPSVVG | 141 | Q9UMS4 | |
| ANIIVQAPPQFTVTP | 411 | A1KZ92 | |
| QAPPQFTVTPKDQVV | 416 | A1KZ92 | |
| PIIPTSGSVPVQKQA | 621 | Q01780 | |
| KRENTTVSPPPVVTQ | 771 | Q6WRI0 | |
| VIPSAATKFPPEITV | 2136 | Q9Y6J0 | |
| GPVVTDPKAPNVVVT | 56 | P52566 | |
| PVTIINQPSVKPAAA | 2896 | P12111 | |
| VPQGTKVLSFTIPQP | 491 | Q7Z591 | |
| TPVDVPVTNPAATIL | 971 | Q6IMN6 | |
| VTPPAVVSSQPKLQT | 726 | Q6VMQ6 | |
| PIQFVVPTPENLVTS | 431 | P10911 | |
| VRTPQSVTAKQPPEI | 141 | Q86UE4 | |
| VPQPVVQSSKPPVVS | 321 | Q13118 | |
| ENIPVTFKSPVPVNS | 241 | Q8IYD9 | |
| ESIKPAPPFNVTVTF | 116 | Q9HBE5 | |
| PVPEIAETVTQTQPV | 66 | Q96AY2 | |
| PTTAQVTIEAQPPKV | 31 | Q00888 | |
| EPVKETVQTTQSPTP | 606 | Q9UPN6 | |
| AFTPIPVDTSQIVLP | 861 | Q92736 | |
| QVSVPLPSPKVQNVS | 711 | Q9H329 | |
| FSSIKVPIVFTPVVP | 756 | Q9C0B2 | |
| QQSLPPPKFTATVET | 491 | Q9UPQ0 | |
| VTPPQGTSVFVIITK | 81 | P56373 | |
| PKASVITTPLQPQAT | 1836 | Q6ZRI0 | |
| TKPVTVVAPQSPTFQ | 351 | P49757 | |
| ATPQTVSVPNKVATP | 161 | Q9HBM6 | |
| QRFTVQIPPSQSTPV | 181 | Q9HBM6 | |
| QSTPVKPVPATTAVQ | 191 | Q9HBM6 | |
| VTVVSQPTEPQPVLI | 696 | Q9H2G2 | |
| SKAQLSVQTSPVPTP | 1336 | O43426 | |
| PTTAEVTIEAQPPKV | 31 | Q00887 | |
| TLVPAPGTQFVKPTV | 186 | Q7Z3K3 | |
| PQVVPTSQVVTLPQA | 476 | Q8N196 | |
| STPQTNTVPIKPLIS | 456 | Q9BTA9 | |
| PEIQPSPFVQSQKRV | 731 | Q9P2P6 | |
| NQTAVKVPTTPASPV | 731 | Q6IE81 | |
| PTTAQVTIEAQPPKV | 31 | Q13046 | |
| TATPTNVDLPQVIPK | 601 | P46087 | |
| PSILQQPISNKPFTT | 1766 | Q9UPX8 | |
| VPPVSLHTQVQSVVP | 196 | P36956 | |
| TVPQPTNVKVVLPAA | 891 | Q9C0B9 | |
| NKTQVIPTTVAAPTP | 231 | P52655 | |
| IPTTVAAPTPAQAQI | 236 | P52655 | |
| PVVDLPTTAQVEPSV | 376 | Q5T1Q4 | |
| PVVVIPQSPVSENVF | 1216 | Q96RL7 | |
| TPKPTVSTPTVNAVQ | 841 | Q9UMS6 | |
| EQKPAQFATTVLPPI | 531 | Q9H6T3 | |
| VPTTPLQVAAPVTVF | 2211 | P12270 | |
| SPQAPTLQVKVSPTS | 106 | Q12772 | |
| PTPVKSTADITVIQP | 1871 | O60281 | |
| PPVVKPQSVTVRLSS | 571 | Q7Z5K2 | |
| KAPVIIIPQSSVSPN | 1761 | Q709C8 | |
| EIVSPTKNQTLVSPP | 581 | Q63HK5 | |
| STTVSPAVQEPPLKV | 846 | P37275 | |
| FVQVKASSPVPATPI | 431 | Q9C026 | |
| PVASLPKQIFQPSVQ | 306 | Q9UBW7 | |
| TVLPAQLAPTKVTQP | 346 | Q9Y6X8 | |
| EQPVFSVSKQSPPIS | 426 | P33981 | |
| LTVPAPTVAATPQLV | 951 | Q9UPP1 | |
| PFKSVFVPTAIVNPV | 481 | Q8TEC5 | |
| PTTAQVTIEAQPPKV | 31 | P11465 | |
| QIPVATQPSVVPVHS | 806 | Q9H4A3 | |
| VIPSVIASTPILPQA | 1571 | Q9H4A3 | |
| PVAVSVAPVAPVAVS | 386 | Q96K80 | |
| TVTSVPKQPGVAPIN | 446 | Q9H4I2 | |
| EIVSVQVPAQTPASP | 226 | Q9H0E7 | |
| VVPATVAAFPVVAPS | 366 | E9PAV3 | |
| SPIQAQDVTVVPSAP | 601 | P54296 | |
| PVTVNLPPEQVTKVT | 461 | Q9Y2G1 |